Shopping Cart 0
Cart Subtotal
USD 0

Syngene International Ltd (SYNGENE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Syngene International Ltd (Syngene), a subsidiary of Biocon Ltd, is a clinical research and manufacturing organisation. The organisation offers research, development and manufacturing programs. It provides discovery chemistry, discovery biology, large molecule development, safety assessment, chemical development, formulation development, stability studies, polymer research, integrated discovery and development, clinical development, bioinformatics, antibody drug conjugates and oligonucleotide synthasis services. Syngene's discovert biology includes molecular biology, protein sciences, cell line development and analysis, antibody generation, screening and assay f biology, ADME and DMPK, in vivo pharmacology, and genomics and translation biology. The organisation serves pharmaceutical and biotech, agrochemical, nutrition, animal health and speciality and performance chemical industries. It works in partnership with global pharmaceutical and biotechnology companies. Syngene is headquartered in Bangalore, Karnataka, India.

Syngene International Ltd (SYNGENE)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Syngene International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Syngene International Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Syngene International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Syngene International Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Syngene International Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Syngene International Ltd, Pharmaceuticals & Healthcare, Deal Details 10

Venture Financing 10

Syngene May Raise Over USD50 Million in Venture Financing 10

Private Equity 11

Silver Leaf Oak Acquires 10% Stake in Syngene International from Biocon Research for USD62.2 Million 11

IVF Trustee Acquires 10% Stake in Syngene International for USD62 Million 13

GE Equity International Mauritius Completes Acquisition Of 7.69% Stake In Syngene International For USD 23 Million 14

Partnerships 16

Artelo Biosciences Enters into Agreement with Syngene International and Aptus Clinical 16

Syngene International Enters into Agreement with Zumutor Biologics 17

Saniona Enters into Agreement with Syngene 18

Syngene International Extends R&D Agreement with Bristol-Myers Squibb 19

Abbott India Enters Into Joint Venture Agreement With Syngene International 20

Equity Offering 21

Syngene International Raises up to USD86 Million in IPO 21

Syngene International Ltd-Key Competitors 23

Syngene International Ltd-Key Employees 24

Syngene International Ltd-Locations And Subsidiaries 25

Head Office 25

Other Locations & Subsidiaries 25

Joint Venture 25

Recent Developments 26

Financial Announcements 26

Apr 25, 2018: Syngene International Q4 net rises 8% to Rs 84 crore 26

Jan 23, 2018: Syngene Reports Revenue of ONR3.99 Billion in Q3 Fiscal 2018 27

Jul 27, 2017: Syngene Q1 FY18 Revenue up 6% to Rs. 308 Cr 28

Apr 27, 2017: Syngene Delivered 14% Revenue Growth in FY17 30

Jan 24, 2017: Syngene Q3 Revenue up by 23% 32

Corporate Communications 33

Apr 27, 2017: Syngene International Appointment of Mr. Jonathan Hunt as Whole Time Director and Mr. Peter Bains, Non-Executive Director stepped down from the Board 33

Appendix 34

Methodology 34

About GlobalData 34

Contact Us 34

Disclaimer 34


List Of Figure

List of Figures

Syngene International Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Syngene International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Syngene International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Syngene International Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Syngene International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Syngene International Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Syngene International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Syngene International Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

Syngene International Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Syngene International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Syngene International Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Syngene International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Syngene International Ltd, Deals By Therapy Area, 2012 to YTD 2018 8

Syngene International Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Syngene May Raise Over USD50 Million in Venture Financing 10

Silver Leaf Oak Acquires 10% Stake in Syngene International from Biocon Research for USD62.2 Million 11

IVF Trustee Acquires 10% Stake in Syngene International for USD62 Million 13

GE Equity International Mauritius Completes Acquisition Of 7.69% Stake In Syngene International For USD 23 Million 14

Artelo Biosciences Enters into Agreement with Syngene International and Aptus Clinical 16

Syngene International Enters into Agreement with Zumutor Biologics 17

Saniona Enters into Agreement with Syngene 18

Syngene International Extends R&D Agreement with Bristol-Myers Squibb 19

Abbott India Enters Into Joint Venture Agreement With Syngene International 20

Syngene International Raises up to USD86 Million in IPO 21

Syngene International Ltd, Key Competitors 23

Syngene International Ltd, Key Employees 24

Syngene International Ltd, Other Locations 25

Syngene International Ltd, Subsidiaries 25

Syngene International Ltd, Joint Venture 25

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Syngene International Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.